Table 1. Baseline characteristics according to the ASST results.
| Total n=75 (%) | ASST | P value | ||
|---|---|---|---|---|
| Positive (n=17) | Negative (n=50) | |||
| Age | 40.5±12.3 | 38.2±11.8 | 41.1±12.4 | 0.489* |
| Gender (male) | 24 (32.0) | 5 (29.4) | 16 (32.0) | 1.000† |
| Urticaria duration (month) | 12 (2-360) | 6 (2-108) | 13 (2-360) | 0.122* |
| Angioedema | 29 (38.7) | 6 (35.3) | 21 (42.0) | 0.777† |
| UAS | 9.9±3.6 | 9.5±4.1 | 10.1±3.6 | 0.722* |
| CU-QoL | 58.0±20.3 | 57.3±18.6 | 57.9±21.6 | 0.863* |
| Atopy | 37 (49.3) | 11 (64.7) | 23 (46.0) | 0.262† |
| Aspirin intolerance | 16 (21.9) | 4 (25.0) | 11 (22.0) | 1.000† |
| Autoantibodies | 21/63 (33.3) | 9/17 (52.9) | 10/38 (26.3) | 0.071† |
| Anti-thyroid | 15/63 (33.3) | 6 (35.3) | 9/47 (19.1) | 0.197† |
| ANA | 8 (10.7) | 4 (23.5) | (8.0) | 0.187† |
| Total IgE (KU/L) | 241.9±351.8 | 238.3±306.6 | 250.2±390.7 | 0.768* |
| ESR (mm/h) | 14.8±11.3 | 11.9±6.3 | 16.0±12.9 | 0.461* |
| CRP (mg/L) | 0.44±0.86 | 0.12±0.33 | 0.60±0.99 | 0.037* |
| Peripheral basophil (% of WBC) | 0.41±0.79 | 0.82±1.24 | 0.28±0.57 | 0.020* |
| Controlled status at baseline | ||||
| Partly/Un-controlled | 37/38 | 11/6 | 23/27 | 0.262† |
P values were obtained by comparison between ASST positive and negative groups.
*Mann-Whitney U test; †Fisher's exact test.